Upon review of a patient's drug profile, which combination may be considered duplication therapy?
Cetirizine and loratadine are considered duplication therapy.
Both cetirizine and loratadine are antihistamines used to treat allergic symptoms, leading to potential therapeutic duplication when prescribed together. This overlap can increase the risk of side effects without additional benefits, as both medications serve similar functions in alleviating allergy-related issues.
Hydralazine is an antihypertensive medication, while loratadine is an antihistamine. These drugs serve different therapeutic purposes, targeting hypertension and allergic reactions, respectively. Therefore, combining them does not constitute duplication therapy, as they do not overlap in their indications or mechanisms of action.
Both cetirizine and loratadine are second-generation antihistamines utilized to manage allergic rhinitis and other allergy symptoms. Prescribing both simultaneously leads to duplication therapy, as they share a similar mechanism of action and therapeutic effects, thereby increasing the risk of adverse effects without substantial therapeutic gain.
Famotidine is a histamine H2 antagonist used primarily for gastrointestinal conditions, such as reducing stomach acid. Cetirizine, as an antihistamine, targets allergic responses. Since they act on different types of histamine receptors and treat different conditions, their use together does not represent duplication therapy.
Hydralazine and famotidine are also used for different indications; hydralazine is for hypertension, while famotidine is for gastrointestinal issues. There is no overlap in their therapeutic roles, making their concurrent use a non-issue regarding duplication therapy.
Duplication therapy arises when two medications with similar effects are prescribed together, increasing the risk of side effects without added benefit. In this case, cetirizine and loratadine both function as antihistamines for allergy relief, making their use together unnecessary and potentially harmful. Understanding drug interactions and therapeutic duplications is crucial in optimizing patient care and minimizing adverse reactions.
Related Questions
View allIn the event of a public health emergency, it may become necessary to...
According to federal law, which of the following medications requires...
A pharmacy must utilize a DEA Form 222 or CSOS to order stock bottles...
Dutasteride is indicated to treat symptoms associated with:
Which of the following vaccines must remain frozen during transportati...
Related Quizzes
View allPharmacy Technician Certification Exam PTCE
PTCE Pharmacy Technician Certification Exam
PTCE Blue Print for Pharmacy Technician Certification
Pharmacy Technician Certification Exam PTCE Blueprint
Pharmacy Technician Certification Exam PTCE Practice Questions
Master The Pharmacy Technician Certification Exam PTCE
Pharmacy Technician Certification Exam Answers
PTCE With Online Test Pharmacy Technician Certification Exam
Certified Pharmacy Technician Certification
Pharmacy Technician Certification Board Practice Exam
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations